Literature DB >> 21972050

Absence of glutamine supplementation prevents differentiation of murine calvarial osteoblasts to a mineralizing phenotype.

Philip M Brown1, James D Hutchison, Julie C Crockett.   

Abstract

Osteoblasts in vitro differentiate from a proliferating to a mineralizing phenotype upon transfer to a medium rich in beta-glycerophosphate and ascorbic acid. The nutritional requirements of the cells at different stages of this differentiation process are not known. In other cell types, nutritional supplementation during surgery can improve the outcome in terms of speed of patient recovery and prognosis. There is therefore the potential for supplementation at the site of fracture repair or bone grafting with critical osteoblast nutritional factors to potentially accelerate healing. In this study we investigate which common cell nutrients are required for the proliferating and mineralizing stages of osteoblast differentiation. Medium containing 5.5 mM glucose was sufficient to achieve maximal proliferation of primary calvarial osteoblasts and human osteoblast cell lines, with some added benefit of additional glutamine supplementation. However, when cells were stimulated to mineralize, glucose was insufficient to support their energetic requirements. Only when cells were supplemented with glucose together with glutamine were high levels of osteocalcin expression observed together with mineralized nodules in culture, suggesting that this would be a useful combination to assess in cultures of primary human osteoblasts to determine whether it may have beneficial effects during fracture surgery, bone grafting, and fixation of uncemented arthroplasty implants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21972050     DOI: 10.1007/s00223-011-9537-6

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  15 in total

1.  Increased glutamine catabolism mediates bone anabolism in response to WNT signaling.

Authors:  Courtney M Karner; Emel Esen; Adewole L Okunade; Bruce W Patterson; Fanxin Long
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

Review 2.  The role of osteoblasts in energy homeostasis.

Authors:  Naomi Dirckx; Megan C Moorer; Thomas L Clemens; Ryan C Riddle
Journal:  Nat Rev Endocrinol       Date:  2019-08-28       Impact factor: 43.330

Review 3.  Metabolomic biomarkers of low BMD: a systematic review.

Authors:  N Panahi; B Arjmand; A Ostovar; E Kouhestani; R Heshmat; A Soltani; B Larijani
Journal:  Osteoporos Int       Date:  2021-07-26       Impact factor: 4.507

Review 4.  Wnt signaling and cellular metabolism in osteoblasts.

Authors:  Courtney M Karner; Fanxin Long
Journal:  Cell Mol Life Sci       Date:  2016-11-26       Impact factor: 9.261

Review 5.  Energy Metabolism of the Osteoblast: Implications for Osteoporosis.

Authors:  Wen-Chih Lee; Anyonya R Guntur; Fanxin Long; Clifford J Rosen
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

Review 6.  Bone Cell Bioenergetics and Skeletal Energy Homeostasis.

Authors:  Ryan C Riddle; Thomas L Clemens
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

7.  Alterations in bone metabolites with age in C57BL/6 mice model.

Authors:  Dhara Patel; Tae Jin Lee; Sandeep Kumar; Sagar Vyavahare; Alison Worth; William D Hill; Mark Hamrick; Carlos M Isales; Rahul S Shinde; Sadanand Fulzele
Journal:  Biogerontology       Date:  2022-09-02       Impact factor: 4.284

Review 8.  Energy metabolism: A newly emerging target of BMP signaling in bone homeostasis.

Authors:  Jingwen Yang; Hiroki Ueharu; Yuji Mishina
Journal:  Bone       Date:  2020-06-05       Impact factor: 4.398

9.  Biphasic regulation of glutamine consumption by WNT during osteoblast differentiation.

Authors:  Leyao Shen; Deepika Sharma; Yilin Yu; Fanxin Long; Courtney M Karner
Journal:  J Cell Sci       Date:  2021-01-11       Impact factor: 5.285

Review 10.  Regulation of Osteoblast Metabolism by Wnt Signaling.

Authors:  Megan C Moorer; Ryan C Riddle
Journal:  Endocrinol Metab (Seoul)       Date:  2018-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.